Immunity and immune modulation in Trypanosoma cruzi infection

Pathogens and Disease

Volumn 73, Issue 9, 2015, Pages

  Cardillo, Fabíola ^a   De Pinho, Rosa Teixeira ^a   Antas, Paulo Renato Zuquim ^a   Mengel, José ^a,b,c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Faculty of Medicine of Petropolis   (Brazil)

^c Rua lo de Maio   (Brazil)

Author keywords

Gamma delta T cell; Interleukin 17; Memory T cell; Myeloid derived suppressor cell (MDSC); Regulatory T cell; Trypanosoma cruzi

Indexed keywords

ADAPTIVE IMMUNITY; ANIMAL; CHAGAS DISEASE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE EVASION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INNATE IMMUNITY; PATHOGENICITY; PATHOLOGY; TRYPANOSOMA CRUZI;

ADAPTIVE IMMUNITY; ANIMALS; CHAGAS DISEASE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNE TOLERANCE; IMMUNITY, INNATE; TRYPANOSOMA CRUZI;

EID: 85010910116     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1093/femspd/ftv082     Document Type: Review

References (107)

1. Abrahamsohn IA, Coffman RL. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J Immunol 1995;155:3955-63.
2. Albareda MC, Laucella SA, Alvarez MG, et al. Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas’ disease patients. Int Immunol 2006;18:465-71.
3. Amezcua Vesely MC, Bermejo DA, Montes CL, et al. B-Cell Response during Protozoan Parasite Infections. J Parasitol Res 2012;2012:362131.
4. Andrade DV, Gollob KJ, Dutra WO. Acute Chagas disease: new global challenges for an old neglected disease. PLoS Neglect Trop D 2014;8:e3010.
5. Arocena AR, Onofrio LI, Pellegrini AV, et al. Myeloid-derived suppressor cells are key players in the resolution of inflammation during a model of acute infection. Eur J Immunol 2013;44:184-94.
6. Azuara V, Grigoriadou K, Lembezat MP, et al. Strain-specific TCR repertoire selection of IL-4-producing Thy-1 dull gamma delta thymocytes. Eur J Immunol 2001;31:205-14.
7. Azuara V, Lembezat MP, Pereira P. The homogeneity of the TCRdelta repertoire expressed by the Thy-1dull gammadelta T cell population is due to cellular selection. Eur J Immunol 1998;28:3456-67.
8. Azuara V, Levraud JP, Lembezat MP, et al. A novel subset of adult gamma delta thymocytes that secretes a distinct pattern of cytokines and expresses a very restricted T cell receptor repertoire. Eur J Immunol 1997;27:544-53.
9. Azuara V, Pereira P. Genetic mapping of two murine loci that influence the development of IL-4-producing Thy-1dull gamma delta thymocytes. J Immunol 2000;165:42-8.
10. Bermejo DA, Jackson SW, Gorosito-Serran M, et al. Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORgammat and Ahr that leads to IL-17 production by activated B cells. Nat Immunol 2013;14:514-22.
11. Bestetti RB, Restini CB. Posaconazole versus benznidazole for chronic Chagas’ disease. New Engl J Med 2014;371:966.
12. Bilate AM, Salemi VM, Ramires FJ, et al. TNF blockade aggravates experimental chronic Chagas disease cardiomyopathy. Microbes Infect 2007;9:1104-13.
13. Bixby LM, Tarleton RL. Stable CD8+ T cell memory during persistent Trypanosoma cruzi infection. J Immunol 2008;181:2644-50.
14. Bonney KM, Engman DM. Chagas heart disease pathogenesis: one mechanism or many? Curr Mol Med 2008;8:510-8.
15. Bonney KM, Engman DM. Autoimmune pathogenesis of Chagas heart disease: looking back, looking ahead. Am J Pathol 2015;185:1537-47.
16. Bonney KM, Taylor JM, Thorp EB, et al. Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease. Parasitol Res 2015;114: 1167-78.
17. Bustamante JM, Bixby LM, Tarleton RL. Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease. Nat Med 2008;14:542-50.
18. Cardillo F, Cunha FQ, Tamashiro WM, et al. NK1.1+ cells and T-cell activation in euthymic and thymectomized C57Bl/6 mice during acute Trypanosoma cruzi infection. Scand J Immunol 2002;55:96-104.
19. Cardillo F, Falcao RP, Rossi MA, et al. An age-related gamma delta T cell suppressor activity correlates with the outcome of autoimmunity in experimental Trypanosoma cruzi infection. Eur J Immunol 1993;23:2597-605.
20. Cardillo F, Nomizo A, Mengel J. The role of the thymus in modulating gammadelta T cell suppressor activity during experimental Trypanosoma cruzi infection. Int Immunol 1998;10: 107-16.
21. Cardillo F, Nomizo A, Postol E, et al. NK1.1 cells are required to control T cell hyperactivity during Trypanosoma cruzi infection. Med Sci Monitor 2004;10:BR259-67.
22. Cardillo F, Postol E, Nihei J, et al. B cells modulate T cells so as to favour T helper type 1 and CD8+ T-cell responses in the acute phase of Trypanosoma cruzi infection. Immunology 2007;122:584-95.
23. Cardillo F, Voltarelli JC, Reed SG, et al. Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect Immun 1996;64:128-34.
24. Cassinotti A, Sarzi-Puttini P, Fichera M, et al. Immunity, autoimmunity and inflammatory bowel disease. Autoimmun Rev 2014;13:1-2.
25. Chien YH, Hampl J. Antigen-recognition properties of murine gamma delta T cells. Springer Semin Immun 2000;22:239-50.
26. Chien YH, Meyer C, Bonneville M. gammadelta T cells: first line of defense and beyond. Annu Rev Immunol 2014;32:121-55.
27. Costa MF, de Negreiros CB, Bornstein VU, et al. Murine IL-17+ Vgamma4 T lymphocytes accumulate in the lungs and play a protective role during severe sepsis. BMC Immunol 2015;16:36.
28. Costa RP, Gollob KJ, Fonseca LL, et al. T-cell repertoire analysis in acute and chronic human Chagas’ disease: differential frequencies of Vbeta5 expressing T cells. Scand J Immunol 2000;51:511-9.
29. Cuervo H, Guerrero NA, Carbajosa S, et al. Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection. J Immunol 2011;187:2656-65.
30. Cunha-Neto E, Bilate AM, Hyland KV, et al. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 2006;39:41-54.
31. Cunha-Neto E, Teixeira PC, Nogueira LG, et al. Autoimmunity. Adv Parasitol 2011;76:129-52.
32. da Costa TA, Silva MV, Mendes MT, et al. Immunomodulation by Trypanosoma cruzi: toward understanding the association of dendritic cells with infecting TcI and TcII populations. J Immunol Res 2014;2014:962047.
33. de Araujo FF, Vitelli-Avelar DM, Teixeira-Carvalho A, et al. Regulatory T cells phenotype in different clinical forms of Chagas’ disease. PLoS Neglect Trop D 2011;5:e992.
34. daMatta Guedes PM, Gutierrez FR, Maia FL, et al. IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis. PLoS Neglect Trop D 2010;4:e604.
35. dos Santos RR, Rossi MA, Laus JL, et al. Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. J Exp Med 1992;175:29-39.
36. Duranti MA, Franzoni L, Sartor G, et al. Trypanosoma cruzi: conformational preferences of antigenic peptides bearing the immunodominant epitope of the B13 antigen. Exp Parasitol 1999;93:38-44.
37. Duthie MS, Kahn M, White M, et al. Both CD1d antigen presentation and interleukin-12 are required to activate natural killer T cells during Trypanosoma cruzi infection. Infect Immun 2005a;73:1890-4.
38. Duthie MS, Kahn M, White M, et al. Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection. Infect Immun 2005b;73:181-92.
39. Duthie MS, Wleklinski-Lee M, Smith S, et al. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein. Infect Immun 2002;70:36-48.
40. Dutra WO, Menezes CA, Magalhaes LM, et al. Immunoregula-tory networks in human Chagas disease. Parasite Immunol 2014;36:377-87.
41. Fares RC, Correa-Oliveira R, de Araujo FF, et al. Identification of phenotypic markers of B cells from patients with Chagas disease. Parasite Immunol 2013;35:214-23.
42. Ferreira RC, Ianni BM, Abel LC, et al. Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/ ‘indeterminate’ and Chagas disease cardiomyopathy patients. Mem I Oswaldo Cruz 2003;98:407-11.
43. Fiuza JA, Fujiwara RT, Gomes JA, et al. Profile of central and effector memory T cells in the progression of chronic human Chagas disease. PLoS Neglect Trop D 2009;3:e512.
44. Galli G, Nuti S, Tavarini S, et al. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J Exp Med 2003;197:1051-7.
45. Galli G, Pittoni P, Tonti E, et al. Invariant NKT cells sustain specific B cell responses and memory. P Natl Acad Sci USA 2007;104:3984-9.
46. Gattass CR, Lima MT, Nobrega AF, et al. Do self-heart-reactive T cells expand in Trypanosoma cruzi-immune hosts? Infect Immun 1988;56:1402-5.
47. Goni O, Alcaide P, Fresno M. Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+)immature myeloid suppressor cells. Int Immunol 2002;14:1125-34.
48. Hunter CA, Ellis-Neyes LA, Slifer T, et al. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J Immunol 1997;158:3311-6.
49. Huss DJ, Mehta DS, Sharma A, et al. In vivo maintenance of human regulatory T cells during CD25 blockade. J Immunol 2015;194:84-92.
50. Koberle F. Chagas’ disease and Chagas’ syndromes: the pathology of American trypanosomiasis. Adv Parasitol 1968;6: 63-116.
51. Kong X, Sun R, Chen Y, et al. gammadeltaT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance. J Immunol 2014;193:1645-53.
52. Kosmaczewska A. Low-dose interleukin-2 therapy: a driver of an imbalance between immune tolerance and autoimmunity. Int J Mol Sci 2014;15:18574-92.
53. Kotner J, Tarleton R. Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice. Infect Immun 2007;75: 861-9.
54. Lanzavecchia A, Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 2001;106:263-6.
55. Leavey JK, Tarleton RL. Cutting edge: dysfunctional CD8+ T cells reside in nonlymphoid tissues during chronic Trypanosoma cruzi infection. J Immunol 2003;170:2264-8.
56. Locksley RM, Scott P. Helper T-cell subsets in mouse leishma-niasis: induction, expansion and effector function. Immunol Today 1991;12:A58-61.
57. Lopes MF, dos Reis GA. Trypanosoma cruzi-induced immunosuppression: blockade of costimulatory T-cell responses in infected hosts due to defective T-cell receptor-CD3 functioning. Infect Immun 1994;62:1484-8.
58. Mariano FS, Gutierrez FR, Pavanelli WR, et al. The involvement of CD4 + CD25+ T cells in the acute phase of Trypanosoma cruzi infection. Microbes Infect 2008;10:825-33.
59. Massilamany C, Gangaplara A, Reddy J. Environmental microbes and uveitis: is microbial exposure always bad? Scand J Immunol 2015;81:469-75.
60. Mengel J, Dare L, Dare GM, et al. An activated murine B cell lymphoma line (A-20) produces a factor-like activity which is functionally related to human natural killer cell stimulatory factor. Eur J Immunol 1992;22:3173-8.
61. Mengel JO, Rossi MA. Chronic chagasic myocarditis pathogenesis: dependence on autoimmune and microvascular factors. Am Heart J 1992;124:1052-7.
62. Miyahira Y, Katae M, Takeda K, et al. Activation of natural killer T cells by alpha-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi. Infect Immun 2003;71:1234-41.
63. Miyahira Y. Trypanosoma cruzi infection from the view of CD8+ T cell immunity-an infection model for developing T cell vaccine. Parasitol Int 2008;57:38-48.
64. Molina I, Gomez i Prat J, Salvador F, et al. Randomized trial of posaconazole and benznidazole for chronic Chagas’ disease. New Engl J Med 2014;370:1899-908.
65. Molina I, Salvador F, Sanchez-Montalva A. Posaconazole versus benznidazole for chronic Chagas’ disease. New Engl J Med 2014;371:966.
66. Morillo CA, Marin-Neto JA, Avezum A, et al. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N Engl J Med 2015;373:1295-306.
67. Nascimento FR, Calich VL, Rodriguez D, et al. Dual role for nitric oxide in paracoccidioidomycosis: essential for resistance, but overproduction associated with susceptibility. J Immunol 2002;168:4593-600.
68. Nihei J, Cardillo F, Dos Santos WL, et al. Administration of a nondepleting anti-CD25 monoclonal antibody reduces disease severity in mice infected with Trypanosoma cruzi. Eur J Mi-crobiol Immunol 2014;4:128-37.
69. Nomizo A, Cardillo F, Postol E, et al. V gamma 1 gammadelta T cells regulate type-1/type-2 immune responses and participate in the resistance to infection and development of heart inflammation in Trypanosoma cruzi-infected BALB/c mice. Microbes Infect 2006;8:880-8.
70. O’Garra A, Stapleton G, Dhar V, et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 1990;2:821-32.
71. Olivieri BP, Cotta-De-Almeida V, Araujo-Jorge T. Benznidazole treatment following acute Trypanosoma cruzi infection triggers CD8+ T-cell expansion and promotes resistance to reinfection. Antimicrob Agents Ch 2002;46:3790-6.
72. Pang Y, Norihisa Y, Benjamin D, et al. Interferon-gamma gene expression in human B-cell lines: induction by interleukin-2, protein kinase C activators, and possible effect of hypomethylation on gene regulation. Blood 1992;80: 724-32.
73. Papathanasiou S, Rickelt S, Soriano ME, et al. Tumor necrosis factor-alpha confers cardioprotection through ectopic expression of keratins K8 and K18. Nat Med 2015;21: 1076-84.
74. Pereira IR, Vilar-Pereira G, Marques V, et al. A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine reprograms immune response and reverses chronic cardiomyopathy. PLoS Pathog 2015;11:e1004594.
75. Pinge-Filho P, Tadokoro CE, Abrahamsohn IA. Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection. Cell Immunol 1999;193:90-8.
76. Pinho RT, da Silva WS, de Castro Cortes LM, et al. Production of MMP-9 and inflammatory cytokines by Trypanosoma cruzi-infected macrophages. Exp Parasitol 2014;147:72-80.
77. Poncini CV, Alba Soto CD, Batalla E, et al. Trypanosoma cruzi induces regulatory dendritic cells in vitro. Infect Immun 2008;76:2633-41.
78. Poncini CV, Ilarregui JM, Batalla EI, et al. Trypanosoma cruzi infection imparts a regulatory program in dendritic cells and T cells via galectin-1-dependent mechanisms. J Immunol 2015;195:3311-24.
79. Pontes-de-Carvalho L, Mengel J, Figueiredo CA, et al. Antigen mimicry between infectious agents and self or environmental antigens may lead to long-term regulation of inflammation. Front Immunol 2013;4:314.
80. Poveda C, Fresno M, Girones N, et al. Cytokine profiling in Chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (a BENEFIT TRIAL sub-study). PLoS One 2014;9:e91154.
81. Procopio DO, Almeida IC, Torrecilhas AC, et al. Glycosylphosphatidylinositol-anchored mucin-like gly-coproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway. J Immunol 2002;169:3926-33.
82. Ramarathinam L, Niesel DW, Klimpel GR. Salmonella ty-phimurium induces IFN-gamma production in murine splenocytes. Role of natural killer cells and macrophages. J Immunol 1993;150:3973-81.
83. Rampazo EV, Amorim KN, Yamamoto MM, et al. Antigen targeting to dendritic cells allows the identification of a CD4 T-cell epitope within an immunodominant Trypanosoma cruzi antigen. PLoS One 2015;10:e0117778.
84. Rassi A, Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet 2010;375:1388-402.
85. Rassi A, Rassi A, Jr, Marin-Neto JA. Posaconazole versus benznidazole for chronic Chagas’ disease. New Engl J Med 2014;371:965.
86. Rei M, Goncalves-Sousa N, Lanca T, et al. Murine CD27(-) Vgamma6(+) gammadelta T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages. P Natl Acad Sci USA 2014;111: E3562-70.
87. Rezende-Oliveira K, Sarmento RR, Rodrigues V, Jr. Production of cytokine and chemokines by human mononuclear cells and whole blood cells after infection with Trypanosoma cruzi. Rev Soc Bras Med Tro 2012;45:45-50.
88. Roffe E, Rothfuchs AG, Santiago HC, et al. IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection. J Immunol 2012;188: 649-60.
89. Sales PA, Jr, Golgher D, Oliveira RV, et al. The regulatory CD4 + CD25+ T cells have a limited role on pathogenesis of infection with Trypanosoma cruzi. Microbes Infect 2008;10: 680-8.
90. Sallusto F, Lanzavecchia A, Araki K, et al. From vaccines to memory and back. Immunity 2010;33:451-63.
91. Sathler-Avelar R, Lemos EM, Reis DD, et al. Phenotypic features of peripheral blood leucocytes during early stages of human infection with Trypanosoma cruzi. Scand J Immunol 2003;58: 655-63.
92. Schmolka N, Serre K, Grosso AR, et al. Epigenetic and transcriptional signatures of stable versus plastic differentiation of proinflammatory gammadelta T cell subsets. Nat Immunol 2013;14:1093-100.
93. Sester DP, Sagulenko V, Thygesen SJ, et al. Deficient NLRP3 and AIM2 inflammasome function in autoimmune NZB Mice. J Immunol 2015;195:1233-41.
94. Sher A, Oswald IP, Hieny S, et al. Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha. J Immunol 1993;150:3982-9.
95. Sokol H. Probiotics and antibiotics in IBD. Dig Dis 2014;32(Suppl 1):10-7.
96. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003;21:685-711.
97. Sullivan NL, Eickhoff CS, Sagartz J, et al. Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion. J Immunol 2015;194:1806-18.
98. Takahashi T, Strober S. Natural killer T cells and innate immune B cells from lupus-prone NZB/W mice interact to generate IgM and IgG autoantibodies. Eur J Immunol 2008;38:156-65.
99. Umezawa ES, Stolf AM, Corbett CE, et al. Chagas’ disease. Lancet 2001;357:797-9.
100. Veras PS, Welby-Borges M, de Santana CD, et al. Leishmania ama-zonensis: participation of regulatory T and B cells in the in vitro priming (PIV) of CBA/J spleen cells susceptible response. Exp Parasitol 2006;113:201-5.
101. Wakita D, Sumida K, Iwakura Y, et al. Tumor-infiltrating IL-17producing gammadelta T cells support the progression of tumor by promoting angiogenesis. Eur J Immunol 2010;40: 1927-37.
102. Werner JM, Busl E, Farkas SA, et al. DX5 + NKT cells display phenotypical and functional differences between spleen and liver as well as NK1.1-Balb/c and NK1.1+ C57Bl/6 mice. BMC Immunol 2011;12:26.
103. Williams MA, Holmes BJ, Sun JC, et al. Developing and maintaining protective CD8+ memory T cells. Immunol Rev 2006;211:146-53.
104. Wojciechowski W, Harris DP, Sprague F, et al. Cytokine-producing effector B cells regulate type 2 immunity to H. poly-gyrus. Immunity 2009;30:421-33.
105. Wood JN, Hudson L, Jessell TM, et al. A monoclonal antibody defining antigenic determinants on subpopulations of mammalian neurones and Trypanosoma cruzi parasites. Nature 1982;296:34-8.
106. Wu P, Wu D, Ni C, et al. gammadeltaT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity 2014;40:785-800.
107. Zingales B, Araujo RG, Moreno M, et al. A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole. Mem I Oswaldo Cruz 2015;110:433-44.